Oct 28, 2024
WACKER performed in Q3 2024 despite the ongoing difficult market environment
Sep 19, 2024
Capital Markets Day 2024: WACKER confirms strategy and long-term growth targets
Sep 17, 2024
MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus
All press releases